Provided by Tiger Trade Technology Pte. Ltd.

iShares Global Healthcare ETF

101.47
+0.61000.60%
Post-market: 101.470.00000.00%19:30 EDT
Volume:100.27K
Turnover:10.13M
Market Cap:4.28B
PE:-98.68
High:101.69
Open:100.73
Low:100.51
Close:100.86
52wk High:107.69
52wk Low:90.24
Shares:42.15M
Float Shares:42.15M
Volume Ratio:0.84
T/O Rate:0.24%
Dividend:1.44
Dividend Rate:1.42%
EPS(TTM):-1.0283
EPS(LYR):-1.0283
ROE:-8.66%
ROA:0.90%
PB:1.10
PE(LYR):-98.68

Loading ...

Eli Lilly Stock (LLY) Gains on Regulatory Win for Experimental Cancer Drug

TIPRANKS
·
10 hours ago

Sector Update: Healthcare Stocks Rise Monday Afternoon

MT Newswires Live
·
11 hours ago

Mediobanca Steps Up Trading Activity in Listed Shares of Philogen

TIPRANKS
·
12 hours ago

Emeis Executes Share Buyback as Mission-Driven Care Group Expands Role in Vulnerable Healthcare

TIPRANKS
·
12 hours ago

FTC issues letters warning hospitals against ‘deceptive’ pricing practices

TIPRANKS
·
12 hours ago

Lilly Expands Oncology Footprint with FDA Win for Pancreatic Cancer Drug

Dow Jones
·
Yesterday

UnitedHealth Group Faces Texas AG Investigation Over Coverage Practices

MT Newswires Live
·
Yesterday

Eli Lilly treatment of pancreatic cancer granted orphan designation

TIPRANKS
·
Yesterday

UnitedHealth Group Faces AG Paxton Investigation Over Coverage Practices

MT Newswires Live
·
Yesterday

UnitedHealth under investigation by Texas AG amid alleged unlawful practices

TIPRANKS
·
Yesterday

Merck & Co Inc Stock (MRK) Moved Down by 3.04% on Oct 5: What Investors Need To Know

TradingKey
·
Yesterday

TRex Bio Files for Nasdaq IPO

MT Newswires Live
·
Yesterday

Merck, Caterpillar Share Losses Lead Dow's 269-Point Drop

Dow Jones
·
Yesterday

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Yesterday

PMV Pharmaceuticals Adds Veteran Investor to Board

TIPRANKS
·
Yesterday

RYET to Enter Malaysian Healthcare Through Exclusive Cogni AI License to BioNexus Gene Lab

GlobeNewswire
·
Yesterday

Gate Bioscience Expands Collaboration and License Agreement with Lilly to Target Difficult-to-Drug Proteins

THOMSON REUTERS
·
Yesterday

Eli Lilly Presents New Ebglyss Data from Phase 3 ADorable-1 Pediatric Atopic Dermatitis Study at Fall Clinical 2026

Reuters
·
Yesterday

JPMorgan Adjusts Price Target on Merck & Co. to $165 From $150, Maintains Overweight Rating

MT Newswires Live
·
Yesterday

Wall Street's US$10 bil India hospital bet sparks a fight over bills

Ranjani Raghavan & Anto Antony / Bloomberg
·
Yesterday